Dr. Thomas Ahrens
Nurse, researcher, and educator at Barnes-Jewish Hospital, USA
Dr. Thomas Ahrens is an American nurse, researcher, and educator at Barnes-Jewish Hospital, specialising in Critical Care Nursing. Dr. Ahrens has more than 25 years of experience as a critical care nurse and is the author of five books, more than 100 papers, and more than 40 scientific publications. His book "Essentials of Oxygenation" received the Book of the Year Award from the American Journal of Nursing. He is a Fellow of the American Academy of Nursing, which named him one of its first Edge Runners in 2006; the award recognises innovations resulting in better care for patients, families, and community. In 2008 he received the "Flame of Excellence Award" from the American Association of Critical Care Nurses. This award recognises sustained contributions of excellence in acute and critical care nursing.
Dr Ahrens is also a grant reviewer for the National Institute of Health and formerly served on the board of directors for AACN. He is a recognised authority in sepsis and has given numerous lectures around the country on this subject.
In 1999, Dr. Ahrens co-founded the company "ICU-USA, Inc". The company operates a website that provides educational information to hospital staff and medical information to patients and families; in particular those in ICU. The website has been endorsed by the American Association of Critical Care Nurses and has been named "The Official Patient and Family Website of the Society of Critical Care Medicine" by the Society of Critical Care Medicine.
To find out more visit: http://www.icu-usa.com
CME Faculty Disclosure: It is the policy of EB Medicine to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-sponsored educational activities. All faculty participating in the planning or implementation of a sponsored activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. In compliance with all ACCME Essentials, Standards, and Guidelines, all faculty for this CME activity were asked to complete a full disclosure statement. The speaker did not report any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) discussed in this educational presentation.
In this programme, recent improvements in the understanding and treatment of sepsis will be presented, including how SARS-COV2 induces sepsis. A review of past therapies and the recent introduction of newer treatments for sepsis will be discussed. Updates from the Surviving Sepsis Campaign will be presented, as will recent studies that address the management of sepsis. Controversies in the treatment and identification of sepsis will be reviewed, as well as case studies using novel treatments in the care of the patient with sepsis. The emphasis on early identification and how to implement protocols in hospitals, from the ED and floor to the ICU will be highlighted. The program emphasises innovative learning strategies in an attempt to help the learner retain more information as well as make the program a more enjoyable event.
By the end of this lecture the attendee will be able to:
- Identify the reasons sepsis is one of the most important public health issues.
- Understand the role of inflammation, endothelial cell dysfunction and altered haemodynamics in severe sepsis.
- Understand SARS-COV2 and its role in sepsis.
- Discuss how the use of lactate, peripheral capillary refill or measures of stroke volume can affect outcomes.
- Discuss the key components of sepsis treatment.
This lecture is equal to 1 CPD Point, 1 AMA PRA Category 1 Credit™, and 1 CE Contact Hour.
Additional CME Info
Release Date: February 1, 2020, Termination Date: January 31, 2023
Accreditation: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of EB Medicine and Continulus. EB Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation: EB Medicine designates this internet enduring material for a maximum of 1 AMA PRA Category 1 Credit™ per lecture. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Commercial Support: This activity received no commercial support.
Earning Credit: In order to earn CME credit, the participant must take the pre-test, listen to the lecture, take the CME post-test, and complete the post-test evaluation.